SAVSU Technologies evo™ Smart Shipping Container for Cold Chain Management of Temperature Sensitive Biologics Debuted at ISCT Conference
SANTA FE, N.M., June 17, 2015 /PRNewswire/ -- SAVSU Technologies a leading designer and manufacturer of innovative high performance passive storage and transport containers for temperature sensitive biologics and pharmaceuticals, recently demonstrated its evo smart shipping container at the 2015 International Society for Cellular Therapy Conference in Las Vegas. SAVSU is a partner in a joint venture with Bothell, WA-based BioLife Solutions, a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Photo - http://photos.prnewswire.com/prnh/20150617/223814
The evo precision thermal shipper and its cloud hosted biologistex application enable customers to pack, ship and track high-value biologic payloads in real time, reducing the need for expensive courier services.
New cellular therapies and regenerative medicines used to treat disease require strict temperature ranges during storage and transport to ensure their viability. The evo's ability to monitor and report on biologic payload conditions including internal and external temperature, light, humidity, shock, and pressure enable users to make sure these critical environments are maintained during shipping. The biologistex app enables users to configure text and email alerts on location, delivery, unpacking, and remaining stability time.
The evo product line and integrated cloud hosted data management system expand on SAVSU's expertise in designing shipping and storage containers for temperature sensitive biologic materials. Three evo models demonstrated at the conference are designed for 2-8 degrees C, CRT and frozen shipments.
"Our new evo product line is the hardware component of the product offering from our biologistex joint venture. It represents our latest thinking about shipping critical, small volume cellular therapies and tissue samples, which are more difficult than large volume shipments. In the case of autologous therapies, we all know that there is a patient depending on a customized cellular therapy to arrive safely and reliably. That was terrific motivation to help create a system that advances the state of the art significantly," says Bruce McCormick, President of SAVSU Technologies.
The joint venture between SAVSU and BioLife Solutions reflects the companies' innovative and strategic approach to solving cold chain management challenges in the delivery of life saving biologic materials.
About SAVSU Technologies
SAVSU is a leading designer and manufacturer of innovative high performance passive storage and transport containers for temperature sensitive biologics and pharmaceuticals. Our mission is to improve global health by greatly reducing the waste and risks associated with the improper freezing and overheating of thermal-sensitive medicines and biologics. SAVSU® has developed proprietary state-of-the-art technology to ultimately lower costs and improve delivery of these most essential materials.
Media & Investor Relations
Celene Bridgford
Director of Marketing, SAVSU Technologies
[email protected]
SOURCE SAVSU Technologies
Share this article